GE Ventures and Stanford Health Care has announced the launch of Evidation Health, an independent company committed to improving health outcomes with evidence-based digital medicine.

Focused on generating real-world clinical and economic evidence for digital health products and platforms, Evidation Health combines health outcomes data with new approaches to predictive analytics to identify and deploy the most effective and efficient patient management strategies and interventions.

Evidation Health CEO, Ms Deborah Kilpatrick, said, "Our company has the core capabilities to make precision digital medicine a reality. We envision a digital health-enabled future where clinical interventions can be customized and concentrated in ways that maximize clinical and economic benefit for payers, providers and, most importantly, patients."

To accelerate commercial progress, Evidation Health joined forces with The Activity Exchange, a digital health company with strong predictive analytics capabilities, and closed its Series A financing in January of 2015. The round was led by GE Ventures, with participation from Asset Management Ventures and Rock Health. The company is focused on forging new partnerships while continuing its corporate and academic collaborations with Humana, Biogen, Sanofi, Harvard Business School and Wharton, amongst others.

Stanford Health Care president and CEO Mr Amir Dan Rubin, said, "Stanford Health Care is committed to delivering integrated solutions to the complex problems patients face, and those solutions will increasingly be advanced through digital health. As an early adopter of electronic health records, virtual visits and precision health, Stanford Health Care is excited to join with GE Ventures to launch Evidation Health to provide real-world assessment and validation of digital health care technologies."